273 related articles for article (PubMed ID: 15689403)
1. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
Zafiriou S; Stanners SR; Saad S; Polhill TS; Poronnik P; Pollock CA
J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.
Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435
[TBL] [Abstract][Full Text] [Related]
6. Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure.
Polhill TS; Saad S; Poronnik P; Fulcher GR; Pollock CA
Am J Physiol Renal Physiol; 2004 Aug; 287(2):F268-73. PubMed ID: 15113747
[TBL] [Abstract][Full Text] [Related]
7. PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose.
Panchapakesan U; Sumual S; Pollock CA; Chen X
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1153-8. PubMed ID: 15886275
[TBL] [Abstract][Full Text] [Related]
8. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
9. The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells.
Panchapakesan U; Pollock CA; Chen XM
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F528-34. PubMed ID: 15113752
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
[TBL] [Abstract][Full Text] [Related]
11. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia.
Makino N; Sugano M; Satoh S; Oyama J; Maeda T
Cell Biochem Biophys; 2006; 44(1):65-71. PubMed ID: 16456235
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
Yu X; Li C; Li X; Cai L
Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
[TBL] [Abstract][Full Text] [Related]
14. The effects of high glucose and atorvastatin on endothelial cell matrix production.
McGinn S; Poronnik P; Gallery ED; Pollock CA
Diabet Med; 2004 Oct; 21(10):1102-7. PubMed ID: 15384957
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
[TBL] [Abstract][Full Text] [Related]
16. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
Fujiwara M; Muragaki Y; Ooshima A
Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism.
Vesey DA; Cheung C; Cuttle L; Endre Z; Gobe G; Johnson DW
J Lab Clin Med; 2002 Nov; 140(5):342-50. PubMed ID: 12434136
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone attenuates TGF-beta(1)-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)gamma.
Maeda A; Horikoshi S; Gohda T; Tsuge T; Maeda K; Tomino Y
Cell Biol Int; 2005 Jun; 29(6):422-8. PubMed ID: 16054559
[TBL] [Abstract][Full Text] [Related]
19. [The antagonistic effects of adrenomedullin on biological events governed by transforming growth factor beta in HK-2 cell line].
Ma C; Wang H
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(8):476-9. PubMed ID: 11798922
[TBL] [Abstract][Full Text] [Related]
20. [The effects of endothelin-1 and selective endothelin receptor-type A antagonist on human renal interstitial fibroblasts in vitro].
Tian X; Tang G; Chen Y
Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):5-9. PubMed ID: 11953117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
